ICICI Lombard General Insurance

Investment case

Motor-TP recovery at a two-year low

Why this business

India's largest private-sector non-life insurer (51.3% owned by ICICI Bank) with FY26 GDPI of Rs 28,713 crore and a ~9.4% overall market share (H1FY25); motor market share 10.5%, group health 10.3% and retail health 4.5% (Q1FY27). It writes motor, health, fire/property, marine and crop business through agents, banks, OEM tie-ups and digital channels, and runs a conservatively invested float (solvency 2.71x). FY26 combined ratio was 102.4% with ROE of 17.8%.

What we believe

1. 01Buying a franchise leader at a cyclical trough: combined ratio 107.2% in Q1FY27 was inflated by ~490 bps of one-offs (Rs 165 cr SC reserve, Rs 63 cr fire losses); adjusted 102.3% is flat YoY and FY26 was 102.4%, with FY26 ROE still 17.8%.
2. 02Motor TP repricing is the cyclical lever: tariffs frozen since 2021-22 and IRDAI has proposed an ~18% average hike (Jun-2025); post the 11-Jun-2026 SC homemaker ruling the GI Council is pushing MoRTH for the first hike in four years - ICICI Lombard's motor COR of 106.6% vs industry 128% makes it the biggest relative beneficiary.
3. 03Health mix shift lifting growth: retail health +51% in FY26 and +50% in Q1FY27 (swung to an operating profit), overall health +69.5% in Q1FY27; health market share up to 4.5% from 3.5%.
4. 04Balance sheet strength: solvency 2.71x vs 1.5x regulatory, almost debt-free, FY26 investment income Rs 4,742 cr (+11.6%), dividend Rs 13.5/share; supports growth capital for the SC-mandated 4-year/6-year long-term TP covers.
5. 05Valuation reset: from ~36x to 30x TTM PE, 4.3x book, with street targets of Rs 1,660-1,960 (Nuvama/Emkay/MOFSL) vs Rs 1,481 price after cuts of 5-21% to FY27E EPS already in the base.

Why now

30.5x TTM PE and 4.3x book (screener, 8-Sep-2026) after a 13-15% post-result fall to a two-year low; screener shows a 10-year average ROE of 18% and 5-year profit CAGR of 12%. Formal 5y average PE not sourced but the stock traded near 36x FY27E (Nuvama) before the derating. EV/EBITDA n.m.; dividend yield 0.9%.

Market disagreement

• Go Digit General Insurance: Go Digit (48x PE, 5.1x P/B, ROE 12.2%, Q1FY27 PAT -38%) is motor-heavy and more exposed to the SC TP ruling at a higher multiple and lower ROE; ICICI Lombard is at 30x with 17.8% FY26 ROE and a diversified health/commercial book.
• Star Health & Allied Insurance: Star Health (39x PE, ROE 7.6%) is a mono-line retail-health insurer with structurally high loss ratios and no motor-TP repricing optionality; ICICI Lombard offers higher ROE at a lower multiple and is gaining retail-health share (+51% FY26 vs Star +11%).
• New India Assurance: New India (49x PE, ROE 4.9%, Q1FY27 loss Rs 239 cr with motor loss Rs 1,297 cr) has a 128%-type motor COR and PSU cost structure; ICICI Lombard's 106.6% motor COR and 2.71x solvency make it the quality way to play a TP tariff hike.

Position sizing

Cyclical Mid cap  3.1% of the PMS on $31 Jul 2026 (August rank 8). Satellite positions are owned for an asymmetry, sized up when the cycle rewards risk and reduced when it does not.

Catalysts

• MoRTH/IRDAI notification of a motor TP premium revision (IRDAI proposal ~18% average; GI Council request Jul-2026) - decision expected 'in coming quarters'.
• Q2FY27 results (mid-Oct-2026): confirmation that ex-one-off combined ratio holds at ~102% and that no further SC-related reserve strengthening is needed.
• Implementation of the 5-Aug-2026 Supreme Court mandate for 4-year (car) / 6-year (2W) long-term TP covers on new vehicles and the uninsured-vehicle (56%) enforcement pilot.

Risks and response

• Motor TP tariff hike not materialising: MOFSL notes visibility on TP hike, commission changes and motor-OD realignment is 'bleak'; without it motor TP unit economics stay 'sub-optimal' and loss ratios rise 12-15% from the SC ruling.
• Growth lag: GDPI grew 7% in FY26 and 8.5% ('n' basis) in Q1FY27 versus industry 9-11% as the company walks away from under-priced motor and commercial lines; commission expense +33% YoY in Q1FY27.
• Investment income normalising: capital gains fell to Rs 183 cr from Rs 380 cr in Q1FY27; equity-market weakness would compress the ~30% of PBT that comes from realised gains.

Thesis-break conditions

Not stated separately on this page; the risk list carries the monitoring triggers.

Review history

• 8 Sep 2026 · Yash Palod · one-pager in "Why We Own What We Own" (p36) · portfolio as of $31 Jul 2026
• 31 Aug 2026 · Classification in the August top-30: Cyclical

Source: Buoyant_Why_We_Own_What_We_Own_Sep2026.pdf (portfolio as of 31 July 2026), p36. Internal; external publication of these fields is controlled by audience policy.